MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

BACKGROUND: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific m...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhayat, Sameer A., Mardin, Wolf Arif, Seggewiß, Jochen, Ströse, Anda Jana, Matuszcak, Christiane, Hummel, Richard, Senninger, Norbert, Mees, Sören Torge, Haier, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659591/
https://www.ncbi.nlm.nih.gov/pubmed/26606261
http://dx.doi.org/10.1371/journal.pone.0143755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659591/
https://www.ncbi.nlm.nih.gov/pubmed/26606261
http://dx.doi.org/10.1371/journal.pone.0143755

Ejemplares similares